AH046 - What's Hot In and Around the Pharmacy Supply Chain, with RSM's Tom Evegan

On this Astonishing Healthcare podcast episode, Tom Evegan, Principal, National Consulting Leader, Life Sciences at RSM, a leading provider of tax, assurance, and consulting services in the US, joins Justin Venneri for a discussion about topics ranging from health policy to drug pricing and how to provide equitable drug access. Tom shares his background and path to RSM, explaining how his experiences at a major pharmaceutical manufacturer, pharmacy benefit manager (PBM), and a biotech launching a new therapy shaped his experience and aided him in becoming a "gross-to-net expert."Tom has helped hundreds of drug manufacturers launch, acquire, or divest assets and bring products from the regulatory phase to commercialization, so he's seen a lot and pays close attention to issues impacting drug prices and market access. Given his broad experience across the pharmaceutical supply chain, almost no topic is off the table. The conversation dives into the Inflation Reduction Act (IRA), the Chevron Ruling and 340B program, AI, why rebates likely aren't going anywhere soon, and the most astounding thing Tom's seen (hint: it relates to GLP-1s)!Related ContentHow to Manage Pharmacy Benefit Spend in a GLP-1 WorldAH021 - Managing Pharmacy Costs in a GLP-1 World, with Bridget MulvennaWhat is NADAC & How Does It Differ From AWP?AH022 - Pharmacy Benefits 101: Pharmaceutical Rebates, with Ben SchusterTo connect with Tom or for more information about RSM's Life Sciences Group/Management Consulting Services, please visit:Connect with Tom Evegan (LinkedIn)Life Sciences | Industries | RSM USScaling at the Speed of Change: BiopharmaFor more information about Capital Rx and this episode, please visit Capital Rx Insights.